Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Beone, Celltrion, Daiichi, Incyte, J&J, Memo, Novo, Sangamo.

Biopharma happenings, including deals and partnerships, and other news in brief: Alnylam, Athira, Biontech, CAMP4, Cormedix, Curevac, Decoy, GSK, Peptidream, Prism, Salarius, Sermonix, Talus.

Clinical updates, including data readouts and publications: Innovent, Insmed, Ovid, Pyxis, Sagimet, Takeda, Werewolf.

Biopharmas raising money in public or private financings, including: Atavistik, Biodexa, CAMP4, DNA Nanobots, Forx, Lixte, Orum, Syremis.

New hires and promotions in the biopharma industry, including: Muvon, Profound, Puretech.

Med-tech firms raising money in public or private financings, including: Medline, Neuraworx Medical Technology, Profound Medical.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Linus Health.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Accendra, Biotronik, Curasight, Envue, Medipost, Owens & Minor, Soin Neuroscience, Teikoku Seiyaku.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Huxley Medical, Pearl.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Antengene, GSK, Sanofi.